Status:

UNKNOWN

Effect of Intraoperative Remifentanil Infusion Rate on Postoperative Tolerance and Analgesic Consumption in Pediatric Laparoscopic Ureteroneocystostomy

Lead Sponsor:

Yonsei University

Conditions:

Pediatrics

Eligibility:

All Genders

1-5 years

Phase:

NA

Brief Summary

Effect of intraoperative remifentanil infusion rate on postoperative tolerance and analgesic consumption in pediatric laparoscopic ureteroneocystostomy.

Eligibility Criteria

Inclusion

  • Pediatric patients (ASA physical status I and II) aged between 1-5 yrs and scheduled elective laparoscopic ureteroneocystostomy

Exclusion

  • cardiovascular, renal, liver disease or growth retardation

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2012

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT01147757

Start Date

June 1 2010

End Date

June 1 2012

Last Update

December 6 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Severance Hospital

Seoul, South Korea, 120-752